TIGIT blockade can stimulate phagocytosis by repolarizing M2-type macrophages to M1-type macrophages, synergizing with CD47 antibodies that block the "don’t eat me" signal, inducing macrophage phagocytosis of acute myeloid leukemia (AML) cells. Here, TIGIT is linked to acute myeloid leukemia.